In a mouse model of spontaneous breast cancer, researchers showed that genetic ablation of CSF-1 does not affect primary tumor incidence or growth, but strongly inhibits the development of metastases through a reduction in TAMs (Lin et al., 2001). This evidence concerns the gene CSF1 and breast cancer.